Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.
Insulin-like growth factor 1 (IGF-1) serum levels have been reported to be altered in Alzheimer's disease patients, and it was suggested that the changes in IGF-1 serum level may play a role in disease pathology and progression. However, this notion remained controversial due to conflicting fin...
Main Authors: | Philip P Ostrowski, Andrew Barszczyk, Julia Forstenpointner, Wenhua Zheng, Zhong-Ping Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4881955?pdf=render |
Similar Items
-
Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
by: Lijun Ge, et al.
Published: (2022-02-01) -
Neurodegeneration Is Associated to Changes in Serum Insulin-like Growth Factors
by: Svetlana Busiguina, et al.
Published: (2000-12-01) -
Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis
by: Yuanfeng Gong, et al.
Published: (2017-04-01) -
Correlation of Serum Insulin-like Growth Factor 1 with Prostate Cancer
by: Mohsen Ayati, et al.
Published: (2012-10-01) -
Expression and significance of insulin-like growth factor-1 in extraocular muscle and serum of children with strabismus
by: Li-Juan Tao, et al.
Published: (2013-08-01)